Christopher Cargill
Tracked across 3 events · 18 articles · First seen Apr 20, 2026 · Last active Sep 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: As CEO of Nxera, Cargill commented on the milestone, highlighting the progress of the muscarinic agonist portfolio.
Aug 26, 2026 · 6 articles
Business
Impact: As President and CEO, Christopher Cargill provided commentary on the company's progress and strategic direction, reinforcing confidence in Nxera's growth.
Aug 07, 2026 · 6 articles
Business
Impact: Christopher Cargill, as President and CEO of Nxera, commented positively on the clinical progress and the portfolio's potential. His statement reflects management's outlook.
Sep 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Christopher Cargill live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard